Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
TEVA PHARMACEUTICAL INDUSTRIES LTD | Director | Ordinary Shares | 104 K | $1.73 M | $16.65 | Jun 15, 2024 | Direct |
Catalent, Inc. | Director | Common Stock | 23.9 K | $888 K | $37.18 | Oct 27, 2023 | Direct |
Certara, Inc. | Director | Common Stock | 18 K | $320 K | $17.77 | May 21, 2024 | Direct |
Certara, Inc. | Director | Restricted Stock Units | 11.9 K | $212 K | $17.77 | May 21, 2024 | Direct |
Tarsus Pharmaceuticals, Inc. | Director | Common Stock | 5.35 K | $147 K | $27.47 | Jun 24, 2024 | Direct |
Tarsus Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 5 K | $55 K | $10.99 | Jun 13, 2024 | Direct |
Tarsus Pharmaceuticals, Inc. | Director | Restricted Stock Units | 0 | $0 | $27.47 | Jun 24, 2024 | Direct |
TEVA PHARMACEUTICAL INDUSTRIES LTD | Director | Restricted Share Units | 0 | Jun 15, 2024 | Direct |